The role of the histoblood ABO group in cancer

References

• Landsteiner K . Zur Kenntniss der antifermentativen, lytischen und agglutinierenden Wirkungen des Blutserums und der Lymphe. Zentralbl. Bakteriol.27, 357–366 (1901).
   Google Scholar
• Palomar College . http://anthro.palomar.edu/vary/vary_3.htm.
   Google Scholar
• He M , WolpinB, RexrodeKet al. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler. Thromb. Vasc. Biol.32(9), 2314–2320 (2012).
   PubMed Web of Science ®Google Scholar
• Dentali F , SironiAP, AgenoWet al. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin. Thromb. Hemost.38(5), 535–548 (2012).
   PubMed Web of Science ®Google Scholar
• Panda AK , PandaSK, SahuAN, TripathyR, RavindranB, DasBK. Association of ABO blood group with severe falciparum malaria in adults: case control study and meta-analysis. Malar. J.10, 309 (2011).
   PubMed Web of Science ®Google Scholar
• Dentali F , SironiAP, AgenoWet al. Relationship between ABO blood group and hemorrhage: a systematic literature review and meta-analysis. Semin. Thromb. Hemost.39(1), 72–82 (2013).
   PubMed Web of Science ®Google Scholar
• Alpoim PN , De Barros PinheiroM, JunqueiraDRet al. Preeclampsia and ABO blood groups: a systematic review and meta-analysis. Mol. Biol. Rep.40(3), 2253–2261 (2013).
   PubMed Web of Science ®Google Scholar
• Aird I , BentallHH, RobertsJA. A relationship between cancer of stomach and the ABO blood groups. Br. Med. J.1(4814), 799–801 (1953).
   PubMedGoogle Scholar
• Amundadottir L , KraftP, Stolzenberg-SolomonRZet al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat. Genet.41(9), 986–990 (2009).
   PubMed Web of Science ®Google Scholar
• Yamamoto F , ClausenH, WhiteT, MarkenJ, HakomoriS. Molecular genetic basis of the histo-blood group ABO system. Nature345(6272), 229–233 (1990).
   PubMed Web of Science ®Google Scholar
• Hosoi E . Biological and clinical aspects of ABO blood group system. J. Med. Invest.55(3–4), 174–182 (2008).
   PubMedGoogle Scholar
• Greenwell P . Blood group antigens: molecules seeking a function?Glycoconj. J.14(2), 159–173 (1997).
   PubMed Web of Science ®Google Scholar
• Segurel L , GaoZ, PrzeworskiM. Ancestry runs deeper than blood: the evolutionary history of ABO points to cryptic variation of functional importance. Bioessays35(10), 862–867 (2013).
   PubMed Web of Science ®Google Scholar
• Zhou S , WelsbyI. Is ABO blood group truly a risk factor for thrombosis and adverse outcomes?World J. Cardiol.6(9), 985–992 (2014).
   PubMedGoogle Scholar
• Aird I , BentallHH, MehiganJA, RobertsJA. The blood groups in relation to peptic ulceration and carcinoma of colon, rectum, breast, and bronchus; an association between the ABO groups and peptic ulceration. Br. Med. J.2(4883), 315–321 (1954).
   PubMedGoogle Scholar
• White C , EisenbergH. ABO blood groups and cancer of the stomach. Yale J. Biol. Med.32, 58–61 (1959).
   PubMedGoogle Scholar
• Mcconnell RB . The Genetics Of Gastro-Intestinal Disorders. Oxford University Press, London (1966).
   Google Scholar
• Wang Z , LiuL, JiJet al. ABO blood group system and gastric cancer: a case-control study and meta-analysis. Int. J. Mol. Sci.13(10), 13308–13321 (2012).
   PubMed Web of Science ®Google Scholar
• Iodice S , MaisonneuveP, BotteriE, SandriMT, LowenfelsAB. ABO blood group and cancer. Eur. J. Cancer46(18), 3345–3350 (2010).
   PubMed Web of Science ®Google Scholar
• Miao SY , ZhouW, ChenL, WangS, LiuXA. Influence of ABO blood group and Rhesus factor on breast cancer risk: a meta-analysis of 9665 breast cancer patients and 244,768 controls. Asia Pac. J. Clin. Oncol.10(2), 101–108 (2014).
   PubMed Web of Science ®Google Scholar
• Poole EM , GatesMA, HighBAet al. ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium. Cancer Causes Control23(11), 1805–1810 (2012).
   PubMed Web of Science ®Google Scholar
• Risch HA , LuL, WangJet al. ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. Am. J. Epidemiol.177(12), 1326–1337 (2013).
   PubMed Web of Science ®Google Scholar
• Zhang BL , HeN, HuangYB, SongFJ, ChenKX. ABO blood groups and risk of cancer: a systematic review and meta-analysis. Asian Pac. J. Cancer Prev.15(11), 4643–4650 (2014).
   PubMedGoogle Scholar
• International Agency for Research on Cancer . http://globocan.iarc.fr/Default.aspx.
   Google Scholar
• Ashley DJ . Blood groups and lung cancer. J. Med. Genet.6(2), 183–186 (1969).
   PubMedGoogle Scholar
• Urun Y , UtkanG, CangirAKet al. Association of ABO blood group and risk of lung cancer in a multicenter study in Turkey. Asian Pac. J. Cancer Prev.14(5), 2801–2803 (2013).
   PubMedGoogle Scholar
• Oguz A , UnalD, TasdemirAet al. Lack of any association between blood groups and lung cancer, independent of histology. Asian Pac. J. Cancer Prev.14(1), 453–456 (2013).
   PubMedGoogle Scholar
• Roberts TE , HasletonP, SwindellR, LawsonR. Blood groups and lung cancer. Br. J. Cancer58(2), 278 (1988).
   PubMed Web of Science ®Google Scholar
• Hirohashi S , InoY, KodamaT, ShimosatoY. Distribution of blood group antigens A, B, H, and I(Ma) in mucus-producing adenocarcinoma of human lung. J. Natl Cancer Inst.72(6), 1299–1305 (1984).
   PubMedGoogle Scholar
• Moldvay J , ScheidP, WildPet al. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma. Clin. Cancer Res.6(3), 1125–1134 (2000).
   PubMed Web of Science ®Google Scholar
• Graziano SL , TatumAH, GonchoroffNJ, NewmanNB, KohmanLJ. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer. Clin. Cancer Res.3(1), 87–93 (1997).
   PubMed Web of Science ®Google Scholar
• Matsumoto H , MuramatsuH, ShimotakaharaTet al. Correlation of expression of ABH blood group carbohydrate antigens with metastatic potential in human lung carcinomas. Cancer72(1), 75–81 (1993).
   PubMed Web of Science ®Google Scholar
• Ogawa J , IwazakiM, InoueH, KoideS, KawadaS, ShohtsuA. Relation of ABH blood group antigen expression to prognosis in lung carcinoma. Tokai J. Exp. Clin. Med.12(1), 49–54 (1987).
   PubMedGoogle Scholar
• Fukumoto K , TaniguchiT, UsamiNet al. The ABO blood group is an independent prognostic factor in patients with resected non-small cell lung cancer. J. Epidemiol.25(2), 110–116 (2015).
   PubMed Web of Science ®Google Scholar
• Lee JS , RoJY, SahinAAet al. Expression of blood-group antigen A – a favorable prognostic factor in non-small-cell lung cancer. N. Engl. J. Med.324(16), 1084–1090 (1991).
   PubMed Web of Science ®Google Scholar
• Leon-Atance P , Moreno-MataN, Gonzalez-AragonesesFet al. Prognostic influence of loss of blood group A antigen expression in pathologic stage I non-small-cell lung cancer. Arch. Bronconeumol.48(2), 49–54 (2012).
   PubMed Web of Science ®Google Scholar
• Ulger AF , KeklikT, KumbasarOOet al. Prognostic significance of blood group antigen expression of tumor tissue in lung cancer patients. Tumori88(5), 395–399 (2002).
   PubMed Web of Science ®Google Scholar
• Gwin JL , Klein-SzantoAJ, ZhangSYet al. Loss of blood group antigen A in non-small cell lung cancer. Ann. Surg. Oncol.1(5), 423–427 (1994).
   PubMed Web of Science ®Google Scholar
• Pastorino U , AndreolaS, TagliabueEet al. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J. Clin. Oncol.15(8), 2858–2865 (1997).
   PubMed Web of Science ®Google Scholar
• Unal D , ErogluC, KurtulN, OguzA, TasdemirA, KaplanB. ABO blood groups are not associated with treatment response and prognosis in patients with local advanced non-small cell lung cancer. Asian Pac. J. Cancer Prev.14(6), 3945–3948 (2013).
   PubMedGoogle Scholar
• Goldenberg IS , HayesMA. Breast carcinoma and ABO blood groups. Cancer11(5), 973–974 (1958).
   PubMed Web of Science ®Google Scholar
• Gates MA , XuM, ChenWY, KraftP, HankinsonSE, WolpinBM. ABO blood group and breast cancer incidence and survival. Int. J. Cancer130(9), 2129–2137 (2012).
   PubMed Web of Science ®Google Scholar
• Dede DS , AksoyS, DizdarOet al. Blood ABO groups and risk of breast cancer. Med. Oncol.27(4), 1433 (2010).
   PubMed Web of Science ®Google Scholar
• Stamatakos M , KontzoglouK, SafioleasP, SafioleasC, MantiC, SafioleasM. Breast cancer incidence in Greek women in relation to ABO blood groups and Rh factor. Int. Semin. Surg. Oncol.6, 14 (2009).
   PubMedGoogle Scholar
• Tryggvadottir L , TuliniusH, RobertsonJM. Familial and sporadic breast cancer cases in Iceland: a comparison related to ABO blood groups and risk of bilateral breast cancer. Int. J. Cancer42(4), 499–501 (1988).
   PubMed Web of Science ®Google Scholar
• Shull JH , JavadpourN, SoaresT, DemossEV. The ABO(H) cell surface antigens in carcinoma and benign lesions of the breast. J. Surg. Oncol.18(2), 193–196 (1981).
   PubMed Web of Science ®Google Scholar
• Gupta RK , SchusterR. Isoantigens A, B and H in benign and malignant lesions of breast. Am. J. Pathol.72(2), 253–257 (1973).
   PubMed Web of Science ®Google Scholar
• Idikio HA , ManickavelV. A, B, H, and Lewis-a and Lewis-b blood group antigens in human breast cancer: correlation with steroid hormone receptor and disease status. J. Cancer Res. Clin. Oncol.119(8), 486–492 (1993).
   PubMed Web of Science ®Google Scholar
• Lee AK , RosenPP, DelellisRAet al. Tumor marker expression in breast carcinomas and relationship to prognosis. An immunohistochemical study. Am. J. Clin. Pathol.84(6), 687–696 (1985).
   PubMed Web of Science ®Google Scholar
• Fleming TC , CaplanHW, HymanGA, KitchinFD. ABO blood groups and polyps of the colon. Br. Med. J.4(5578), 526–527 (1967).
   PubMedGoogle Scholar
• Khalili H , WolpinBM, HuangESet al. ABO blood group and risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev.20(5), 1017–1020 (2011).
   PubMed Web of Science ®Google Scholar
• Halvorsen TB . ABO blood groups, rhesus types, and colorectal adenocarcinoma. A retrospective study of 747 cases. Scand. J. Gastroenterol.21(8), 979–983 (1986).
   PubMed Web of Science ®Google Scholar
• Bakalakos EA , KimJA, YoungDC, MartinEW, Jr. Determinants of survival following hepatic resection for metastatic colorectal cancer. World J. Surg.22(4), 399–404; discussion 404–395 (1998).
   PubMed Web of Science ®Google Scholar
• Cao X , WenZS, SunYJ, LiY, ZhangL, HanYJ. Prognostic value of ABO blood group in patients with surgically resected colon cancer. Br. J. Cancer111(1), 174–180 (2014).
   PubMed Web of Science ®Google Scholar
• Schoentag R , PrimusFJ, KuhnsW. ABH and Lewis blood group expression in colorectal carcinoma. Cancer Res.47(6), 1695–1700 (1987).
   PubMed Web of Science ®Google Scholar
• Ernst C , ThurinJ, AtkinsonBet al. Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissues. Am. J. Pathol.117(3), 451–461 (1984).
   PubMed Web of Science ®Google Scholar
• Yuan M , ItzkowitzSH, PalekarAet al. Distribution of blood group antigens A, B, H, LewisA, and LewisB in human normal, fetal, and malignant colonic tissue. Cancer Res.45(9), 4499–4511 (1985).
   PubMed Web of Science ®Google Scholar
• Le Pendu J , MarionneauS, Cailleau-ThomasAet al. ABH and Lewis histo-blood group antigens in cancer. APMIS109(1), 9–31 (2001).
   PubMed Web of Science ®Google Scholar
• Marionneau S , Le Moullac-VaidyeB, Le PenduJ. Expression of histo-blood group A antigen increases resistance to apoptosis and facilitates escape from immune control of rat colon carcinoma cells. Glycobiology12(12), 851–856 (2002).
   PubMed Web of Science ®Google Scholar
• Beasley WH . The ABO blood groups of carcinoma of the oesophagus and of benign prostatic hyperplasia. J. Clin. Pathol.17, 42–44 (1964).
   PubMed Web of Science ®Google Scholar
• Kvist E , KroghJ, HjortbergP. Prognostic variables in patients with prostate cancer: influence of blood group ABO (H), the Rhesus system, age, differentiation, tumour stage and metastases. Int. Urol. Nephrol.24(4), 417–423 (1992).
   PubMedGoogle Scholar
• Wajsman Z , SaroffJ, MurphyGP. Blood group distribution in prostatic cancer patients. J. Surg. Oncol.9(3), 289–291 (1977).
   PubMed Web of Science ®Google Scholar
• Chastonay P , HurlimannJ, GardiolD. Biological tissue markers in benign and malignant disease of the human prostate. Virchows Arch. A Pathol. Anat. Histopathol.410(3), 221–229 (1986).
   PubMedGoogle Scholar
• Ghazizadeh M , KagawaS, TakigawaH, KurokawaK, NumotoS. Specific red cell adherence test in benign and malignant lesions of the prostate. Br. J. Urol.55(4), 405–407 (1983).
   PubMedGoogle Scholar
• Li Q , YuCH, YuJHet al. ABO blood group and the risk of hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B. PLoS ONE7(1), e29928 (2012).
   PubMed Web of Science ®Google Scholar
• Hsiao LT , LiuNJ, YouSL, HwangLC. ABO blood group and the risk of cancer among middle-aged people in Taiwan. Asia Pac. J. Clin. Oncol.11(4), e31–e36 (2015).
   PubMed Web of Science ®Google Scholar
• Mathew T , GuptaRK. Isoantigens A, B and H in primary liver malignancies. Pathology13(3), 571–577 (1981).
   PubMed Web of Science ®Google Scholar
• Segi M , FujisakuS, KuriharaM, MoniwaH. Cancer of cervix uteri and ABO blood groups. Tohoku J. Exp. Med.66(1), 50 (1957).
   PubMedGoogle Scholar
• Kaur I , SinghIP, BhasinMK. Blood groups in relation to carcinoma of cervix uteri. Hum. Hered.42(5), 324–326 (1992).
   PubMed Web of Science ®Google Scholar
• Yuzhalin AE , KutikhinAG. ABO and Rh blood groups in relation to ovarian, endometrial and cervical cancer risk among the population of south-east Siberia. Asian Pac. J. Cancer Prev.13(10), 5091–5096 (2012).
   PubMedGoogle Scholar
• Adelusi B . Haemoglobin genotype, ABO blood groups and carcinoma of the cervix. J. Trop. Med. Hyg.80(7), 152–154 (1977).
   PubMed Web of Science ®Google Scholar
• Lindgren A , StendahlU, BrodinT, LundbladA, SallstromJ, BuschC. Blood group antigen expression and prognosis in squamous cell carcinoma of the uterine cervix. Anticancer Res.6(2), 255–258 (1986).
   PubMed Web of Science ®Google Scholar
• Gupta S , GuptaYN, SinghIJ, SanyalB, KhannaS, RaniA. Tissue isoantigens A, B, and H in carcinoma of the cervix uteri: their clinical significance. J. Surg. Oncol.16(1), 71–77 (1981).
   PubMed Web of Science ®Google Scholar
• Vogel F . Controversy in human genetics. ABO blood groups and disease. Am. J. Hum. Genet.22(4), 464–475 (1970).
   PubMed Web of Science ®Google Scholar
• Aird I , LeeDR, RobertsJA. ABO blood groups and cancer of oesophagus, cancerof pancreas, and pituitary adenoma. Br. Med. J.1(5180), 1163–1166 (1960).
   PubMedGoogle Scholar
• Macafee AL . ABO blood groups and carcinoma of pancreas. Ulster Med. J.33(2), 129–131 (1964).
   PubMedGoogle Scholar
• Wolpin BM , ChanAT, HartgePet al. ABO blood group and the risk of pancreatic cancer. J. Natl Cancer Inst.101(6), 424–431 (2009).
   PubMedGoogle Scholar
• Willis JA , OlsonSH, OrlowIet al. A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival. Clin. Cancer Res.18(14), 3942–3951 (2012).
   PubMed Web of Science ®Google Scholar
• Wolpin BM , KraftP, GrossMet al. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res.70(3), 1015–1023 (2010).
   PubMed Web of Science ®Google Scholar
• Woo SM , JooJ, LeeWJet al. Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case–control study. J. Korean Med. Sci.28(2), 247–251 (2013).
   PubMed Web of Science ®Google Scholar
• Sun W , WenCP, LinJet al. ABO blood types and cancer risk – a cohort study of 339,432 subjects in Taiwan. Cancer Epidemiol.39(2), 150–156 (2015).
   PubMed Web of Science ®Google Scholar
• Pelzer U , KleinF, BahraMet al. Blood group determinates incidence for pancreatic cancer in Germany. Front. Physiol.4, 118 (2013).
   PubMed Web of Science ®Google Scholar
• Nakao M , MatsuoK, HosonoSet al. ABO blood group alleles and the risk of pancreatic cancer in a Japanese population. Cancer Sci.102(5), 1076–1080 (2011).
   PubMed Web of Science ®Google Scholar
• Greer JB , YazerMH, RavalJS, BarmadaMM, BrandRE, WhitcombDC. Significant association between ABO blood group and pancreatic cancer. World J. Gastroenterol.16(44), 5588–5591 (2010).
   PubMed Web of Science ®Google Scholar
• Ben Q , WangK, YuanY, LiZ. Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study. Int. J. Cancer128(5), 1179–1186 (2011).
   PubMed Web of Science ®Google Scholar
• Duan YF , ZhuF, LiXDet al. Association between ABO gene polymorphism (rs505922) and cancer risk: a meta-analysis. Tumour Biol.36(7), 5081–5087 (2015).
   PubMedGoogle Scholar
• Krawczyk M , MihalacheF, HoblingerA, AcalovschiM, LammertF, ZimmerV. Pancreatic cancer risk variant ABO rs505922 in patients with cholangiocarcinoma. World J. Gastroenterol.17(41), 4640–4642 (2011).
   PubMed Web of Science ®Google Scholar
• Rummel S , ShriverCD, EllsworthRE. Relationships between the ABO blood group SNP rs505922 and breast cancer phenotypes. BMC Med. Genet.13(1), 41 (2012).
   PubMedGoogle Scholar
• Watkins WM . The ABO blood group system: historical background. Transfus. Med.11(4), 243–265 (2001).
   PubMed Web of Science ®Google Scholar
• Dipta TF , HossainAZ. The Bombay blood group: are we out of risk?Mymensingh Med. J.20(3), 536–540 (2011).
   PubMedGoogle Scholar
• Li J , LiS, LiuQet al. Effects of ABO and FUT2 genetic transcription absence on ABH histo-blood group antigen expression in lung cancer patients. Asian Pac. J. Cancer Prev.12(12), 3201–3206 (2011).
   PubMedGoogle Scholar
• Kawai S , KatoS, ImaiH, OkadaY, IshiokaC. Suppression of FUT1 attenuates cell proliferation in the HER2-overexpressing cancer cell line NCI-N87. Oncol. Rep.29(1), 13–20 (2013).
   PubMed Web of Science ®Google Scholar
• Gao N , LiuJ, LiuDet al. c-Jun transcriptionally regulates alpha 1, 2-fucosyltransferase 1 (FUT1) in ovarian cancer. Biochimie107(Pt B), 286–292 (2014).
   PubMedGoogle Scholar
• Ciolczyk-Wierzbicka D , BodziochM, GilD, ZmudzinskaD, Dembinska-KiecA, LaidlerP. Expression of fucosyltransferases contributes to melanoma invasive phenotype. Med. Chem.3(5), 418–424 (2007).
   PubMed Web of Science ®Google Scholar
• Wolpin BM , KraftP, XuMet al. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol. Biomarkers Prev.19(12), 3140–3149 (2010).
   PubMed Web of Science ®Google Scholar
• Su KJ , HoCC, LinCWet al. Combinations of FUT2 gene polymorphisms and environmental factors are associated with oral cancer risk. Tumour Biol. doi:10.1007/s13277-015-4367-1 (2015) ( Epub ahead of print).
   Google Scholar
• Duell EJ , BonetC, MunozXet al. Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population. Int. J. Cancer136(4), 880–893 (2015).
   PubMed Web of Science ®Google Scholar
• Michaud DS . Role of bacterial infections in pancreatic cancer. Carcinogenesis34(10), 2193–2197 (2013).
   PubMed Web of Science ®Google Scholar
• National Institutes of Health . www.nih.gov/precision-medicine-initiative-cohort-program.
   Google Scholar